← Back to Clinical Trials
Recruiting NCT06781047

NCT06781047 Effects of Trunk-Focused Rehabilitation on Spinal Mobility, Trunk Control, and Hand Functions in Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06781047
Status Recruiting
Phase
Sponsor Saglik Bilimleri Universitesi
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-05-15
Primary Completion 2025-05-25

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Trunk Focused Rehabilitation (TFR)Conventional Rehabilitation (CR)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-05-15 with a primary completion date of 2025-05-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Main Purpose: This study aims to investigate the effects of trunk-focused rehabilitation on trunk control, spinal mobility, and manual skills in adolescents with cerebral palsy (CP). Secondary Purpose: To investigate its effects on functional health.

Eligibility Criteria

Inclusion Criteria: 1. Levels 1 and 2 according to Gross Motor Function Classification System (GMFCS) 2. Viking Speech Scale Turkish version/(VSS-T) 1-2 level, understood to speak and able to take commands 3. Adolescents with CP between the ages of 12-18 4. Those whose guardian / legal representative and themselves have received an Informed Voluntary Consent Form 5. No hip dislocation 6. Scoliosis below 25 degrees according to the radiographic evaluation made in the last 6 months Exclusion Criteria: 1. Having had any surgery related to the intrathecal baclofen pump 2. Having botulinum toxin injection treatment or orthopedic surgery within the last 6 months 3. Having severe vision, hearing, and cognitive deficiencies 4. Acute medical illness

Contact & Investigator

Central Contact

Gül EVDALI, MScPT

✉ gulevdali@hotmail.com

📞 +90 544 368 60 26

Principal Investigator

Seval KUTLUTÜRK YIKILMAZ, PhD

PRINCIPAL INVESTIGATOR

University of Health Sciences Hamidiye Faculty of Health Sciences

Frequently Asked Questions

Who can join the NCT06781047 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06781047 currently recruiting?

Yes, NCT06781047 is actively recruiting participants. Contact the research team at gulevdali@hotmail.com for enrollment information.

Where is the NCT06781047 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06781047 clinical trial?

NCT06781047 is sponsored by Saglik Bilimleri Universitesi. The principal investigator is Seval KUTLUTÜRK YIKILMAZ, PhD at University of Health Sciences Hamidiye Faculty of Health Sciences. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology